ArticleOncotarget2015

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.

Christine Di Cresce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.